Pfizer PFE
US equityMarket cap rank #116Drug Manufacturers - GeneralCAR-T TherapyInfectious DiseaseCancer Research
$29.39 −$0.06 (-0.20%)
Market closed · Nov 9, 1:00 am ET · Last extended-hours $29.35 -0.14%
Open$29.07
Prev close$29.45
Day range$28.54 – $29.43
Volume48.32M
Market cap$167.52B
P/E (TTM)42.0
Dividend yield5.85%
Analyst view
ConsensusBuy
Analysts17
Average target$31.29+6.5% vs. price
- Buy 35%
- Hold 59%
- Sell 6%
Low $25.00Now $29.39Avg $31.29High $36.00
Recent rating changes
The last 20 actions on file set price targets from $25.00 to $36.00, averaging $32.33.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 6 Nov 2026 | Freedom Capital Markets | BUY | $34.00 |
| 5 Nov 2026 | DZ BANK AG | HOLD | – |
| 4 Nov 2026 | UBS | HOLD | $30.00 |
| 4 Nov 2026 | BofA Securities | HOLD | – |
| 4 Nov 2026 | Scotiabank | BUY | $35.00 |
| 4 Nov 2026 | BMO Capital | BUY | $35.00 |
| 4 Nov 2026 | Citi | HOLD | $30.00 |
| 4 Nov 2026 | Guggenheim | BUY | $33.00 |
| 3 Nov 2026 | Jefferies | BUY | $36.00 |
| 3 Nov 2026 | Barclays | SELL | $25.00 |
| 27 Oct 2026 | Guggenheim | BUY | $31.00 |
| 26 Oct 2026 | Scotiabank | BUY | $33.00 |
| 26 Oct 2026 | Jefferies | BUY | $36.00 |
| 12 Oct 2026 | BMO Capital | BUY | $35.00 |
| 12 Oct 2026 | Guggenheim | BUY | $31.00 |
| 9 Oct 2026 | BofA Securities | HOLD | $29.00 |
| 9 Oct 2026 | J.P. Morgan | HOLD | $30.00 |
| 8 Oct 2026 | Cantor Fitzgerald | HOLD | $28.00 |
| 8 Oct 2026 | DBS | BUY | $35.00 |
| 8 Oct 2026 | Jefferies | BUY | $36.00 |
No comments yet — be the first to weigh in on PFE.
Sign in to join the discussion.